Clinical Trial: Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood Disorders

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07910318) titled 'Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood Disorders' on Oct. 27.

Brief Summary: Tobacco smoking is significantly more common among individuals with mood disorders, such as major depressive disorder (MDD) and bipolar disorder, compared to the general population. Chronic smoking in these conditions is often linked to more severe symptoms, frequent episodes, and reduced overall quality of life. However, the biological mechanisms linking tobacco smoking to brain alterations and clinical outcomes in mood disorders remain incompletely understood.

The primary purpose of this study is to examine whether chronic t...